Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus

被引:63
作者
Luzi, L
Hering, BJ
Socci, C
Raptis, G
Battezzati, A
Terruzzi, I
Falqui, L
Brandhorst, H
Brandhorst, D
Regalia, E
Brambilla, E
Secchi, A
Perseghin, G
Maffi, P
Bianchi, E
Mazzaferro, V
Gennari, L
DiCarlo, V
Federlin, K
Pozza, G
Bretzel, RG
机构
[1] UNIV MILAN, SAN RAPHAEL SCI INST, DEPT INTERNAL MED, MILAN, ITALY
[2] UNIV MILAN, SAN RAPHAEL SCI INST, DEPT SURG, MILAN, ITALY
[3] UNIV GIESSEN, DEPT MED 3, W-6300 GIESSEN, GERMANY
[4] UNIV GIESSEN, POLICLIN, W-6300 GIESSEN, GERMANY
[5] NATL CANC INST, LIVER TRANSPLANTAT UNIT, I-20133 MILAN, ITALY
关键词
insulin resistance; glucose metabolism; hepatic glucose production; immunosuppressive therapy; islet secretion;
D O I
10.1172/JCI118710
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The intraportal injection of human pancreatic islets has been indicated as a possible alternative to the pancreas transplant in insulin-dependent diabetic patients. Aim of the present work was to study the effect of intraportal injection of purified human islets on: (a) the basal hepatic glucose production; (b) the whole body glucose homeostasis and insulin action; and (c) the regulation of insulin secretion in insulin-dependent diabetes mellitus patients bearing a kidney transplant. 15 recipients of purified islets from cadaver donors (intraportal injection) were studied by means of the infusion of labeled glucose to quantify the hepatic glucose production. Islet transplanted patients were subdivided in two groups based on graft function and underwent: (a) a 120-min euglycemic insulin infusion (1 mU/kg/min) to assess insulin action; (b) a 120-min glucose infusion (+75 mg/dl) to study the pattern of insulin secretion. Seven patients with chronic uveitis on the same immunosuppressive therapy as grafted patients, twelve healthy volunteers, and seven insulin-dependent diabetic patients with combined pancreas and kidney transplantation were also studied as control groups. Islet transplanted patients have: (a) a higher basal hepatic glucose production (HGP: 5.1+/-1.4 mg/kg/min; P<0.05 with respect to all other groups) if without graft function, and a normal HGP (2.4+/-0.2 mg/kg/min) with a functioning graft; (b) a defective tissue glucose disposal (3.9+/-0.5 mg/kg/min in patients without islet function and 5.3+/-0.4 mg/kg/min in patients with islet function) with respect to normals (P<0.01 for both comparisons); (c) a blunted first phase insulin peak and a similar second phase secretion with respect to controls. In conclusion, in spite of the persistence of an abnormal pattern of insulin secretion, successful intraportal islet graft normalizes the basal HGP and improves total tissue glucose disposal in insulin-dependent diabetes mellitus.
引用
收藏
页码:2611 / 2618
页数:8
相关论文
共 27 条
[21]  
ROBERTSON RP, 1992, NEW ENGL J MED, V327, P1861
[22]   IMMUNOCYTOCHEMICAL DETECTION AND CHARACTERIZATION OF INTRAHEPATIC HUMAN PANCREATIC-ISLETS AFTER COMBINED LIVER-ISLET ALLOTRANSPLANTATION [J].
SCOPSI, L ;
ANDREOLA, S ;
SOCCI, C ;
BERTUZZI, F ;
DICARLO, V ;
POZZA, G ;
RILKE, F ;
GENNARI, L ;
COLELLA, G ;
REGALIA, E ;
MAZZAFERRO, V .
CELL TRANSPLANTATION, 1994, 3 (06) :499-508
[23]   ENDOCRINOMETABOLIC EFFECTS OF WHOLE VERSUS SEGMENTAL PANCREAS ALLOTRANSPLANTATION IN DIABETIC-PATIENTS - A 2-YEAR FOLLOW-UP [J].
SECCHI, A ;
DUBERNARD, JM ;
LAROCCA, E ;
LEFRANCOIS, N ;
MELANDRI, M ;
MARTIN, X ;
TOURAINE, JL ;
TRAEGER, J ;
POZZA, G .
TRANSPLANTATION, 1991, 51 (03) :625-629
[24]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[25]  
SUTHERLAND DER, 1994, TRANSPLANT REV, V8, P185
[26]  
WIELKO J, 1976, J AM CHEM SOC, V98, P7631
[27]   CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY DECREASES INSULIN RESISTANCE IN TYPE-1 DIABETES [J].
YKIJARVINEN, H ;
KOIVISTO, VA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (04) :659-666